Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma

Biochemical Journal

Volumn 316, Issue 3, 1996, Pages 905-913

  Willars, Gary B ^a   Challiss, R A John ^a   Stuart, Jamie A ^a   Nahorski, Stefan R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; CALCIUM ION; CARBACHOL; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INOSITOL 1,4,5 TRISPHOSPHATE; LIPID; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PHORBOL DIBUTYRATE; PHORBOL ESTER; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; THAPSIGARGIN;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ELECTROPORATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CARBACHOL; CELL LINE; CHO CELLS; CRICETINAE; CYTOSOL; ENZYME ACTIVATION; ENZYME INHIBITORS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; ISOENZYMES; KINETICS; LITHIUM; N-METHYLSCOPOLAMINE; NEUROBLASTOMA; PHORBOL 12,13-DIBUTYRATE; PHOSPHATIDYLINOSITOLS; PROTEIN KINASE C; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; RECOMBINANT PROTEINS; SCOPOLAMINE DERIVATIVES; SIGNAL TRANSDUCTION; TERPENES; THAPSIGARGIN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029736712     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/bj3160905     Document Type: Article

References (44)

1. Berridge, M. J. (1993) Nature (London) 361, 315-325
2. Mullaney, I., Dodd, M. W., Buckley, N. and Milligan, G. (1993) Biochem. J. 289, 125-131
3. Wojcikiewicz, R. J. H., Furuichi, T., Nakade, S., Mikoshiba, K. and Nahorski, S. R. (1994) J. Biol. Chem. 269, 7963-7969
4. Wojcikiewicz, R. J. H., Tobin, A. B. and Nahorski, S. R. (1993) Trends Pharmacol. Sci. 14, 279-285
5. Wojcikiewicz, R. J. H., Tobin, A. B. and Nahorski, S. R. (1994) J. Neurochem. 63, 177-185
6. Fisher, S. K., Slowiejko, D. W. and McEwen, E. L. (1994) Neurochem. Res. 19, 549-554
7. Menniti, F. S., Takemura, H., Oliver, K. G. and Putney, Jr., J. W. (1991) Mol. Pharmacol. 40, 727-733
8. Barr, A. J. and Watson, S. P. (1994) Mol. Pharmacol. 46, 266-273
9. Labarca, R., Janowsky, A., Patel, J. and Paul, S. M. (1984) Biochem. Biophys. Res. Commun. 123, 703-709
10. Vincentini, L. M., Virgilio, F. D., Ambrosini, A., Pozzan, T. and Meldolesi, J. (1985) Biochem. Biophys. Res. Commun. 127, 310-317
11. Orellana, S., Solski, P. and Brown, J. H. (1987) J. Biol. Chem. 262, 1638-1643
12. Lai, W. S. and El-Fakahany, E. E. (1988) J. Pharmacol. Exp. Ther. 244, 41-50
13. Pearce, B., Morrow, C. and Murphy S. (1988) J. Neurochem. 50, 936-944
14. Kopp, R., Mayer, P. and Pfeiffer, A. (1990) Biochem. J. 269, 73-78
15. Murphy, N. P., McCormack, J. G., Ball, S. G. and Vaughan, P. F. T. (1992) Biochem. J. 282, 645-650
16. Willars, G. B. and Nahorski, S. R. (1995) Br. J. Pharmacol. 114, 1133-1142
17. Lambert, D. G., Ghataorre, A. S. and Nahorski, S. R. (1989) Eur. J. Pharmacol. 165, 71-77
18. Grynkiewicz, G., Poenie, M. and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450
19. Lowry, O. H., Rosebrough, L. W., Farr, L. W. and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275
20. Jenkinson, S., Nahorski, S. R. and Challiss, R. A. J. (1994) Mol. Pharmacol. 46, 1138-1148
21. Burford, N. T., Tobin, A. B. and Nahorski, S. R. (1995) J. Pharmacol. Exp. Ther. 274, 134-142
22. Leli, U., Shea, T. B., Cataldo, A., Hauser, G., Grynspan, F., Beerman, M. L., Liepkalns, V. A., Nixon, R. A. and Parker, P. J. (1993) J. Neurochem. 60, 289-298
23. Willars, G. B. and Nahorski, S. R. (1995) Mol. Pharmacol. 47, 510-517
24. Lambert, D. G. and Nahorski, S. R. (1990) Biochem. J. 265, 555-562
25. Eberhard, D. A. and Holz, R. W. (1988) Trends Neurosci. 11, 517-520
26. Conway, B. R., Withiam-Leitch, M. and Rubin, R. P. (1993) Mol. Pharmacol. 43, 286-292
27. Snoek, G. T., Westerman, J., Wouters, F. S. and Wirtz, K. W. A. (1993) Biochem. J. 291, 649-656
28. Kaziro, Y., Itoh, H., Kozasa, T., Nakafuku, M. and Satoh, T. (1991) Annu. Rev. Biochem. 60, 349-400
29. Ryu, S. H., Kim, U.-H., Wahl, M. I., Brown, A. B., Carpenter, G., Huang, K.-P. and Rhee, S. G. (1990) J. Biol. Chem. 265, 17941-17945
30. Tobin, A. B. and Nahorski, S. R. (1993) J. Biol. Chem. 268, 9317-9823
31. Tobin, A. B., Keys, B. and Nahorski, S. R. (1993) FEBS Lett. 335, 353-357
32. Azzi, A., Boscoboinik, D. and Hensey, C. (1992) Eur. J. Biochem. 208, 547-557
33. Hulme, E. C. and Birdsall, N. J. M. (1992) in Receptor-ligand Interactions - A Practical Approach (Hulme, E. C., ed.), pp. 63-176, Oxford University Press, Oxford
34. Hepler, J. R., Earp, H. S. and Harden, T. K. (1988) J. Biol. Chem. 263, 7610-7619
35. Pfeilschifter, J., Ochsner, M., Whitebread, S. and De Gasparo, M. (1989) Biochem. J. 262, 285-291
36. Jones, J. A., Owen, P. J. and Boarder, M. R. (1990) Br. J. Pharmacol. 101, 521-526
37. Lin, W.-W., Lee, C. Y. and Chuang, D.-M. (1990) Biochem. Biophys. Res. Commun. 168, 512-519
38. Cioffi, C. L. and Fisher, S. K. (1990) J. Neurochem. 54, 1725-1734
39. King, W. G. and Rittenhouse, S. E. (1989) J. Biol. Chem. 264, 6070-6074
40. Boarder, M. R. and Challiss, R. A. J. (1992) Br. J. Pharmacol. 107, 1140-1145
41. Challiss, R. A. J., Wilkes, L. C., Patel, V., Purkiss, J. R. and Boarder, M. R. (1993) FEBS Lett. 327, 157-160
42. Alblas, J., van Ellen, I., Khanum, A. and Moolenaar, W. H. (1995) J. Biol. Chem. 270, 8944-8951
43. Walsh, J. H., Bouzyk, M. and Rozengurt, E. (1993) J. Cell. Physiol. 156, 333-340
44. Zamani, M. R., Dupere, R. B. and Bristow, D. R. (1995) J. Neurochem. 65, 160-169